Global Fertility Supplements Market Is Anticipated To Witness Significant Growth Prospects With Rising CAGR By 2025|Grand View Research, Inc.
The global fertility
supplements market size is projected to reach USD 2.39 billion by 2025,
according to a new report by Grand View Research, Inc. It is anticipated to
expand at a CAGR of 7.4% during the
forecast period. The declining fertility rates owing to the rise in consumption
of alcohol, caffeine, and cigarettes is anticipated to fuel the demand for
fertility supplements.
OTC
fertility supplement segment is expected to witness significant growth in
emerging economies owing to the rising consumer awareness regarding the health
benefits and nutritional value of these products. Self-medication, cost
effectiveness, and convenience of direct purchase is expected to boost the
demand of fertility supplements over the forecast period.
Key
participants in the market include Fairhaven
Health, Orthomol, Vitabiotics, TTK Healthcare, Lenus Pharma among others
Browse Research
Report On fertility supplements Market:
Factors
such as growing geriatric population and rising interest for preventive
healthcare have surged the demand for herbal fertility supplements, in turn
spurring the growth of the fertility supplements market. Consumers are looking
for ingredients such as grape seed extracts, primrose oil, and red clover in
products having minimum side effects and high efficiencies. Manufacturers are
focusing on providing a blend of natural and synthetic ingredients to cater to
consumer demand across the globe.
Further key findings from the report suggest:
·
In terms of revenue, natural
fertility supplements is projected to ascend at a CAGR of 8.6% over the
forecast period
·
Tablets and capsules segment
contributed approximately over 68.7% to the total market in 2018
·
Over the counter fertility
supplements led the market in 2018, constituting a revenue share of over 79.3%
in 2018
·
Asia Pacific is expected to witness
the fastest growth over the forecast period. Expansion of retail chains in
countries such as India, Japan, and China has increased the dietary supplements
consumption in this region
·
The fertility supplements market
represents a highly competitive landscape. Key players dominating the market
space have been focusing on various strategic initiatives including mergers and
acquisitions, product innovation, and portfolio expansion
·
Key participants in the market
include Fairhaven Health, Orthomol, Vitabiotics, TTK Healthcare, Lenus Pharma
among others
Government
policies like ‘one-child-per-couple’ subjected to forced sterilizations or
abortions resulted in decreasing the fertility of women. However, abolishment
of one and two child per couple policies and major amendments in family
planning regulations are expected to have a positive effect on fertility rate.
This factor is anticipated to hinder the market growth in China.
Rising
number of doctors in Italy for initiating the advice for their patients to
consume fertility supplements to help them to cope up with fertility issues, in
combination with Rx-medicine based therapies is expected to remain a favorable
factor for the market.
Browse Press
Release of this report:
Grand
View Research has segmented the global fertility supplements market on the
basis of ingredient, product, end use, distribution channel:
Fertility Supplements Ingredient Outlook (Revenue, USD
Million, 2014 - 2025)
·
Natural
·
Synthetic/ Blend of Natural &
Synthetic
Fertility Supplements Product Outlook (Revenue, USD
Million, 2014 - 2025)
·
Capsules
·
Tablets
·
Soft gels
·
Powders
·
Liquids
Fertility Supplements End Use Outlook (Revenue, USD
Million, 2014 - 2025)
·
Men
·
Women
Fertility Supplements Distribution Channel Outlook
(Revenue, USD Million, 2014 - 2025)
·
OTC
·
Prescribed
Increasing
importance of food products such as avocados, olive oil, whole grains, and high
fat dairy products used in increasing fertility is expected to amplify the
scope of functional food and beverages in near future resulting in hindering
the overall growth.
Increasing
adoption of herbal medicines (botanicals) owing to rising concerns regarding
the harmful effects associated with traditional pharma drugs is anticipated to
create growth opportunities for the product manufacturers. Various government
initiatives for creating awareness about the advancements in supplement
research and superior technology have helped consumers make supplement choices
based on what is good for their health rather than picking products on the
basis of packaging and impressive marketing.
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment